UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Study to Determine how Patients with Endometrial, Ovarian, Hepatocellular Carcinoma, Carcinoid or Islet Cell Cancer Respond to Treatment
    Mohammed Milhem
  2. Study to Establish Database that will Collect Clinical and Survey Data Outcomes of Head and Neck Squamous Cell Carcinoma
    Nitin Pagedar
  3. Trial for Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
    Ayman El-Sheikh
  4. Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome
    Ayman El-Sheikh
  5. Study of How Women Tolerate Chemotherapy
    David Bender
  6. Effectiveness pf Positron Emission Tomography (PET) Scan on Tumors
    M. Sue O'Dorisio
  7. Study of Oral Sapacitabine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia
    Thomas Carter
  8. EVErolimus for Renal Cancer Ensuing Surgical Therapy, a Phase III Study
    Daniel Vaena
  9. Study for Patients with Esophageal or Gastroesophageal Cancer
    Taher Abu Hejleh
  10. Anti-Cancer Activity of Alisertib in Patients with PTCL
    Brian Link
  11. Cell Transplant Study for Multiple Myeloma, POEMS, or Multiple Myeloma with Amyloidosis
    Guido Tricot
  12. Phase 1/2 Study Epigenetic Modification of BRAF-mutated Metastatic Melanoma: Treatment of a Resistant Disease Using Decitabine Combined with Vemurafenib
    Mohammed Milhem
  13. A Phase 1, open-label, multi-center, dose escalation study of the safety, tolerability, pharmacodynamic and pharmacokinetic properties of intravenous GC4419 in combination with radiation and chemother…
    John Buatti
  14. A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide, Bortezomib and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone in Subjects…
    Sarah Holstein
  15. A Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Effect of Vandetanib on Cellular Markers of Proliferation and Apoptosis in Invasive Breast Cancer
    Ronald Weigel
  16. Phase 1b, Open-label, Multicenter Study of Urelumab (BMS-663513) in Combination with Rituximab in Subjects with Relapsed/Refractory B-Cell Malignancies
    Brian Link
  17. A phase II randomized, multicenter study of treatment-free remission in chronic myeloid leukemia in chronic phase (CML-CP) patients who achieve and sustain MR4.5 after switching to nilotinib
    Thomas Carter
  18. A Phase III, Multicenter, Double-Blind, Randomized, Placebo- Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-0431A (A Fixed-Dose Combination Tablet of Sitagliptin and Metformin) in…
    Eva Tsalikian
  19. A Randomized Phase II Study Comparing Two Different Conditioning Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) for Children with Juvenile Myelomonocytic Leukemia (JMML)
    Ayman El-Sheikh
  20. SynCardia Freedom Driver System Study
    Jennifer Goerbig-Campbell

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.